Roundup Cancer Lawsuit News

New Roundup Cancer Lawsuit Filed In California

A recent Monsanto Roundup lawsuit was filed in California where a majority of the claims have originated.

Tuesday, March 14, 2017 - A new Monsanto Roundup lawsuit has been filed in California, where the vast majority of such claims have been centered. The plaintiff claims that they contracted cancer as a result of using Monsanto's Roundup products and was never warned of the medically researched connections to cancer the product held. California has a largely agricultural economy and widespread use of Roundup, which has led to the state becoming the home for most of the nation's Roundup cancer lawsuits. Even the multidistrict litigation is taking place in the U.S. District Court for the Northern District of California.

The Monsanto Roundup cancer lawyer representing the plaintiff claims that Monsanto had been well aware of the cancer connections its Roundup products had been linked to and illegally decided against warning consumers about this connection. The claims allege that the profits generated by the highly profitable Roundup weedkiller line made those marketing the product not want to affect those margins by introducing a warning label that involved cancer, even if that was what would be best for the consumers.

The active ingredient in Roundup is glyphosate, which the Roundup cancer attorneys representing the plaintiff's claim are the chemical linking Roundup to an increased risk for cancer. This argument is backed up by the presentation of glyphosate's spotty history under EPA review and at least five medical studies that have discovered a correlation between glyphosate and an increased risk for cancer. The latest of these studies to be published was conducted in 2009, though the research into the link between glyphosate and cancer is ongoing.

This correlation has been reflected around the world, as in March of 2015 the highly-regarded International Agency for Research on Cancer declared that glyphosate would be classified as a possible carcinogen. In response to this, the state of California pursued drug labeling on Roundup products that directly warned consumers that glyphosate was being considered a possible carcinogen by many reputable agencies and medical studies. There have even been accusations that Monsanto was involved in scientific fraud in their attempts to initially get glyphosate cleared for use in their product.

Monsanto has remained steadfast in their defense of the product's safety and continue to fight the claims that glyphosate is a carcinogen. However, the number of Roundup cancer lawsuits continues to grow. There have been enough claims filed nationwide that in early October the Judicial Panel on Multidistrict Litigation decided to consolidate federal lawsuits filed against Monsanto into multidistrict litigation and transferred the litigation to the Northern District of California.

Monsanto Roundup cancer lawyers around the country have noted that there are likely thousands of potential plaintiffs that could file suit against Monsanto, especially given the ubiquitous use of the product. This latest Roundup lawsuit filed in California is just one of the latest Roundup users that got wind of the developing legal actions being taken against Monsanto. The MDL is expected to progress over the course of 2017, though at this time there has been no schedule for potential bellwethers announced.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.